Vagal modulation of spinal nicotine-induced inhibition of the inflammatory response mediated by descending antinociceptive controls
- PMID: 12941374
- DOI: 10.1016/s0028-3908(03)00224-7
Vagal modulation of spinal nicotine-induced inhibition of the inflammatory response mediated by descending antinociceptive controls
Abstract
Noxious stimuli activate neuroendocrine axes, inhibiting inflammation, an effect that is powerfully attenuated by ongoing activity in subdiaphragmatic vagal afferents. To evaluate whether this inhibitory effect of vagal afferent activity is mediated by descending antinociceptive control, we tested whether antagonizing descending antinociceptive controls: (i) enhances the inhibition of inflammation produced by spinal nicotine (which stimulates central terminals of nociceptors) and (ii) occludes the enhancing effect of subdiaphragmatic vagotomy, in the rat. Spinal intrathecal co-administration of the alpha-adrenergic receptor antagonist phentolamine and the non-selective opioid receptor antagonist naloxone, and acute subdiaphragmatic vagotomy each produced enhancement, with similar magnitude, of nicotine-induced inhibition of plasma extravasation, produced by the potent inflammatory mediator, bradykinin. The combination of subdiaphragmatic vagotomy and intrathecal receptor antagonists, however, produced no further enhancement compared to each treatment alone. These findings support the suggestion that activity in descending antinociceptive controls modulates noxious stimulus-induced inhibition of inflammation and the vagal modulation of noxious stimulus-induced inhibition of inflammation is mediated by descending antinociceptive controls.
Similar articles
-
Role of vagal afferents and spinal pathways modulating inhibition of bradykinin-induced plasma extravasation by intrathecal nicotine.J Neurophysiol. 1994 Sep;72(3):1199-207. doi: 10.1152/jn.1994.72.3.1199. J Neurophysiol. 1994. PMID: 7807204
-
Vagal branches involved in inhibition of bradykinin-induced synovial plasma extravasation by intrathecal nicotine and noxious stimulation in the rat.J Physiol. 1997 Jan 15;498 ( Pt 2)(Pt 2):473-81. doi: 10.1113/jphysiol.1997.sp021873. J Physiol. 1997. PMID: 9032694 Free PMC article.
-
Inhibition of bradykinin-induced plasma extravasation produced by noxious cutaneous and visceral stimuli and its modulation by vagal activity.J Neurophysiol. 1997 Sep;78(3):1285-92. doi: 10.1152/jn.1997.78.3.1285. J Neurophysiol. 1997. PMID: 9310420
-
Vagal afferent modulation of nociception.Brain Res Brain Res Rev. 1992 May-Aug;17(2):77-99. doi: 10.1016/0165-0173(92)90009-b. Brain Res Brain Res Rev. 1992. PMID: 1327371 Review.
-
The role of vagal visceral afferents in the control of nociception.Prog Brain Res. 2000;122:273-87. doi: 10.1016/s0079-6123(08)62145-7. Prog Brain Res. 2000. PMID: 10737065 Review.
Cited by
-
Involvement of Acetylcholine Receptors in Cholinergic Pathway-Mediated Protection Against Autoimmune Diabetes.Front Immunol. 2019 May 15;10:1038. doi: 10.3389/fimmu.2019.01038. eCollection 2019. Front Immunol. 2019. PMID: 31156627 Free PMC article.
-
Mechanosensitive duodenal afferents contribute to vagal modulation of inflammation in the rat.J Physiol. 2004 Jan 1;554(Pt 1):227-35. doi: 10.1113/jphysiol.2003.056804. J Physiol. 2004. PMID: 14678504 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
